Lexaria Bioscience Corp.

Lexaria Bioscience Corp. - PE Ratioverified

LEXX

Price:

$0.5402

Market Cap:

$11.04M

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technolog...[Read more]

Industry

Biotechnology

IPO Date

2021-01-12

Stock Exchange

NASDAQ

Ticker

LEXX

The PE Ratio as of June 2026 (TTM) for Lexaria Bioscience Corp. (LEXX) is -1.15

According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -1.15. This represents a change of -50.28% compared to the average of -2.31 of the last 4 quarters.

Lexaria Bioscience Corp. (LEXX) Historical PE Ratio (quarterly & annually)

How has LEXX PE Ratio performed in the past?

The mean historical PE Ratio of Lexaria Bioscience Corp. over the last ten years is -3.75. The current -1.15 PE Ratio has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), LEXX's PE Ratio was at its highest in in the February 2021 quarter at 16.53. The PE Ratio was at its lowest in in the February 2024 quarter at -14.30.

Quarterly (TTM)
Annual

Average

-3.75

Median

-2.96

Minimum

-8.32

Maximum

-1.04

Lexaria Bioscience Corp. (LEXX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lexaria Bioscience Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 700.22%

Maximum Annual PE Ratio = -1.04

Minimum Annual Increase = -83.97%

Minimum Annual PE Ratio = -8.32

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.33-83.97%
2024-8.32700.22%
2023-1.04-56.45%
2022-2.39-64.69%
2021-6.76114.30%
2020-3.1514.08%
2019-2.7772.22%
2018-1.61-65.95%
2017-4.72-12.63%
2016-5.4061.45%

Lexaria Bioscience Corp. (LEXX) Average PE Ratio

How has LEXX PE Ratio performed in the past?

The current PE Ratio of Lexaria Bioscience Corp. (LEXX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.56

5-year avg

-3.97

10-year avg

-3.75

Lexaria Bioscience Corp. (LEXX) PE Ratio vs. Peers

How is LEXX’s PE Ratio compared to its peers?

Lexaria Bioscience Corp.’s PE Ratio is greater than Hoth Therapeutics, Inc. (-1.33), greater than Allarity Therapeutics, Inc. (-1.99), greater than Lixte Biotechnology Holdings, Inc. (-6.73), less than Entero Therapeutics, Inc. (-1.15), less than Clearside Biomedical, Inc. (-0.05), less than Cingulate Inc. (-0.99), less than BriaCell Therapeutics Corp. (-0.24), less than CASI Pharmaceuticals, Inc. (-0.06), less than Processa Pharmaceuticals, Inc. (-0.20), less than Curis, Inc. (-0.35),

Build a custom stock screener for Lexaria Bioscience Corp. (LEXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexaria Bioscience Corp. (LEXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lexaria Bioscience Corp.'s PE Ratio?

How is the PE Ratio calculated for Lexaria Bioscience Corp. (LEXX)?

What is the highest PE Ratio for Lexaria Bioscience Corp. (LEXX)?

What is the 3-year average PE Ratio for Lexaria Bioscience Corp. (LEXX)?

What is the 5-year average PE Ratio for Lexaria Bioscience Corp. (LEXX)?

How does the current PE Ratio for Lexaria Bioscience Corp. (LEXX) compare to its historical average?